SOURCE: Medical Care Technologies Inc.

January 14, 2010 07:30 ET

Medical Care Technologies Inc. Completes New Version of Tracking Device for Alzheimer's and Dementia

LONDON--(Marketwire - January 14, 2010) - Medical Care Technologies Inc. (OTCBB: MDCE) today announced completion of version 5.1 of the Trackker™ technology for patients suffering with Alzheimer's and Dementia. MDCE's wireless Trackker™ technology assists in providing safety and behavioral information for treatment. The purpose behind the Trackker™ is to allow remote access to the Caregiver, medical facility, and the patient's family to be able to know at all times where patients are situated. The first target markets are Alzheimer's and Dementia patients.

The Trackker™ uses wireless connections to link a GPS monitor that is worn by the patient and is linked to a 24/7 monitoring service. By programming the GPS to certain safety zones, the service can send a phone or email alert to a caregiver immediately. The Global Positioning System (GPS) is a worldwide radio-navigation system formed from a constellation of 24 satellites and their ground stations. GPS uses these "man-made stars" as reference points to calculate positions accurate to a matter of meters. GPS systems typically track patients in open areas outside of buildings however, the Patient Tracker system has the ability to monitor the location of patients within and around facilities. At Medical Care Technologies, we believe that GPS will become almost as basic as the telephone, we feel it will become a universal utility.

As the Chinese population ages at a rapid rate, diseases like Alzheimer's and Dementia are on the increase, and MDCE is developing new ways to assist such patients. The safety and clinical information provided by our Trackker™ technology is crucial for medical professionals and caregivers to help treat those who suffer from this type of disease.

According to the Alzheimer's Disease International, as of 2008, there are an estimated 30 million people with dementia worldwide. By 2050, it is projected that this figure will have increased to over 100 million. Much of the increase will be in developing countries. Already more than 60% of people with dementia live in developing countries, but by 2040 this will rise to 71%. The fastest growth in the elderly population is taking place in China, India, and their south Asian and western Pacific neighbours. In addition, China has nearly 19 million patients who have been diagnosed as suffering with Alzheimer's disease.

Ning Wu, President of MCTI, states, "While behaviour changes hourly or sometimes by the minute in patients with Alzheimer's and Dementia, our traditional ways of evaluating, documenting and treating such behaviour can be assisted by utilizing our Trackker™ technology. We are excited to be able to now integrate the Trackker™ to the Tele-Health™ Suite which will now offer new solutions to healthcare and offer comfort to families of those afflicted with Alzheimer's and Dementia."

About Medical Care Technologies Inc.

Medical Care Technologies Inc. ( is traded under the symbol MDCE on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended to constitute a healthcare delivery and wellness site, dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business technology and information systems to assist the Asian health industry -- physicians, pharmacists, medical institutions, and consumers, in accessing medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals. Further information on the Company can be found at and the company's website at

Safe Harbor Statement

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding: MDCE's products, services, capabilities, performance, opportunities, development and business outlook, guidance on our future financial results and other projections or measures of our future performance; the amount and timing of the benefits expected from strategic initiatives and acquisitions or from deployment of new or updated technologies, products, services or applications; and other potential sources of additional revenue. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: lack of operating history, transitioning from a development company to an operating company, difficulties in distinguishing MDCE's products and services, ability to deploy MDCE's services and products, market acceptance of our products and services; operational difficulties relating to combining acquired companies and businesses; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and healthcare and pharmaceutical industries, and our ability to attract and retain qualified personnel. Other risks and uncertainties may include, but are not limited to: lack of or delay in market acceptance and fluctuations in customer demand, dependence on a limited number of significant customers, reliance on third party vendors and strategic partners, ability to meet future capital requirements on acceptable terms, continuing uncertainty in the global economy, and compliance with federal and state regulatory requirement. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements. There can be no assurance that the acquisition of GUC's assets will close. MDCE must issue 57,300,000 shares of its common stock to GUC, or GUC's designees in order to close the acquisition. Accounting for the anticipated cancelation of 57,300,000 shares by Patricia Traczykowski, MDCE will have 98,900,000 shares of its common stock issued and outstanding upon the closing of the acquisition.

Contact Information